The business problem is to support the Value and Implementation (V&I), Outcomes Research teams in Hematology with a primary focus on lymphomas, to enable sustained patient access to Merck's innovations and improve patient health outcomes.
Requirements
- Advanced or professional degree in a relevant discipline (e.g., Outcomes Research, Health Economics, Epidemiology, Pharmaceutical Administration, Public Health, Health Policy, Medicine, or Clinical Pharmacy)
- 5+ years relevant experience following advanced or professional degree
- Oncology experience
- Biopharmaceutics
- Clinical Pharmacy
- Data Management
- Epidemiology
- Health Economics
- Health Technology Assessment (HTA)
- Hematology
Responsibilities
- Support the value evidence teams in hematology and lead the execution of value evidence projects in lymphomas for in-line and pipeline products.
- Critically assess drivers and barriers to reimbursement and market access in collaboration with internal teams, and provide input into clinical, payer/access, marketing and value evidence generation strategies and programs.
- In collaboration with internal teams and external partners, design non-interventional and data synthesis studies, author study protocols, develop measurement questionnaires, case report forms, data analysis plans, final study reports, scientific presentations, and publications.
- Responsible for study-related contracting, budgets, and vendor/partner management.
- Develop American Managed Care Pharmacy (AMCP) dossiers for US payers, and Global Value Dossiers.
- Develop supplementary clinical data package for submission to Health Technology Assessment (HTA) agencies in close partnership with country affiliates and HTA statistics group.
- Support country affiliates to understand local evidence generation needs, adapt health economic evaluations, customize outcomes research documents, such as protocols and reimbursement dossiers, according to local requirements.
Other
- PhD in a relevant discipline (e.g., Outcomes Research, Health Economics, Epidemiology, Pharmaceutical Administration, Health Policy, Public Health)
- 10% travel requirements
- Domestic relocation
- No VISA sponsorship
- Hybrid flexible work arrangements
